AAAAAA

   
Results: 1-17 |
Results: 17
Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors
Authors: Webber, SE Marakovits, JT Dragovich, PS Prins, TJ Zhou, R Fuhrman, SA Patick, AK Matthews, DA Lee, CA Srinivasan, B Moran, T Ford, CE Brothers, MA Harr, JEV Meador, JW Ferre, RA Worland, ST
Citation: Se. Webber et al., Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors, BIOORG MED, 11(20), 2001, pp. 2683-2686
Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Authors: Pressel, SL Davis, BR Wright, JT Geraci, TS Kingry, C Ford, CE Piller, LB Bettencourt, J Kimmel, B Lusk, C Parks, H Simpson, LM Nwachuku, C Furberg, CD
Citation: Sl. Pressel et al., Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), CONTR CL TR, 22(1), 2001, pp. 29-41
Baseline characteristics of participants in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Authors: Grimm, RH Margolis, KL Papademetriou, V Cushman, WC Ford, CE Bettencourt, J Alderman, MH Basile, JN Black, HR DeQuattro, V Eckfeldt, J Hawkins, CM Perry, HM Proschan, M
Citation: Rh. Grimm et al., Baseline characteristics of participants in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT), HYPERTENSIO, 37(1), 2001, pp. 19-27
Language in time: The rhythm and tempo of spoken interaction.
Authors: Ford, CE
Citation: Ce. Ford, Language in time: The rhythm and tempo of spoken interaction., LANG SOC, 30(2), 2001, pp. 298-301
The Hypertension Detection and Follow-Up Program
Authors: Davis, BR Ford, CE
Citation: Br. Davis et Ce. Ford, The Hypertension Detection and Follow-Up Program, CLINICAL TRIALS IN HYPERTENSION, 2001, pp. 27-60
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors
Authors: Dragovich, PS Zhou, R Webber, SE Prins, TJ Kwok, AK Okano, K Fuhrman, SA Zalman, LS Maldonado, FC Brown, EL Meador, JW Patick, AK Ford, CE Brothers, MA Binford, SL Matthews, DA Ferre, RA Worland, ST
Citation: Ps. Dragovich et al., Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors, BIOORG MED, 10(1), 2000, pp. 45-48
Substituted benzamide inhibitors of human rhinovirus 3C protease: Structure-based design, synthesis, and biological evaluation
Authors: Reich, SH Johnson, T Wallace, MB Kephart, SE Fuhrman, SA Worland, ST Matthews, DA Hendrickson, TF Chan, F Meador, J Ferre, RA Brown, EL DeLisle, DM Patick, AK Binford, SL Ford, CE
Citation: Sh. Reich et al., Substituted benzamide inhibitors of human rhinovirus 3C protease: Structure-based design, synthesis, and biological evaluation, J MED CHEM, 43(9), 2000, pp. 1670-1683
Web-based analyses of e-journal impact: Approaches, problems, and issues
Authors: Harter, SP Ford, CE
Citation: Sp. Harter et Ce. Ford, Web-based analyses of e-journal impact: Approaches, problems, and issues, J AM S INFO, 51(13), 2000, pp. 1159-1176
Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides
Authors: Dragovich, PS Zhou, R Skalitzky, DJ Fuhrman, SA Patick, AK Ford, CE Meador, JW Worland, ST
Citation: Ps. Dragovich et al., Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides, BIO MED CH, 7(4), 1999, pp. 589-598
Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids
Authors: Dragovich, PS Webber, SE Prins, TJ Zhou, R Marakovits, JT Tikhe, JG Fuhrman, SA Patick, AK Matthews, DA Ford, CE Brown, EL Binford, SL Meador, JW Ferre, RA Worland, ST
Citation: Ps. Dragovich et al., Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids, BIOORG MED, 9(15), 1999, pp. 2189-2194
HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data
Authors: Cooksley, CD Hwang, LY Waller, DK Ford, CE
Citation: Cd. Cooksley et al., HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data, INT J STD A, 10(12), 1999, pp. 795-802
Collaborative construction of task activity: Coordinating multiple resources in a high school physics lab
Authors: Ford, CE
Citation: Ce. Ford, Collaborative construction of task activity: Coordinating multiple resources in a high school physics lab, RES LANG S, 32(4), 1999, pp. 369-408
Cost of hospitalizations for heart failure: Sodium retention versus other decompensating factors
Authors: Bennett, SJ Saywell, RM Zollinger, TW Huster, GA Ford, CE Pressler, ML
Citation: Sj. Bennett et al., Cost of hospitalizations for heart failure: Sodium retention versus other decompensating factors, HEART LUNG, 28(2), 1999, pp. 102-109
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease
Authors: Patick, AK Binford, SL Brothers, MA Jackson, RL Ford, CE Diem, MD Maldonado, F Dragovich, PS Zhou, R Prins, TJ Fuhrman, SA Meador, JW Zalman, LS Matthews, DA Worland, ST
Citation: Ak. Patick et al., In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease, ANTIM AG CH, 43(10), 1999, pp. 2444-2450
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes
Authors: Matthews, DA Dragovich, PS Webber, SE Fuhrman, SA Patick, AK Zalman, LS Hendrickson, TF Love, RA Prins, TJ Marakovits, JT Zhou, R Tikhe, J Ford, CE Meador, JW Ferre, RA Brown, EL Binford, SL Brothers, MA DeLisle, DM Worland, ST
Citation: Da. Matthews et al., Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes, P NAS US, 96(20), 1999, pp. 11000-11007
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure - Activity studiesof ketomethylene-containing peptidomimetics
Authors: Dragovich, PS Prins, TJ Zhou, R Fuhrman, SA Patick, AK Matthews, DA Ford, CE Meador, JW Ferre, RA Worland, ST
Citation: Ps. Dragovich et al., Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure - Activity studiesof ketomethylene-containing peptidomimetics, J MED CHEM, 42(7), 1999, pp. 1203-1212
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P-1 lactam moieties as L-glutamine replacements
Authors: Dragovich, PS Prins, TJ Zhou, R Webber, SE Marakovits, JT Fuhrman, SA Patick, AK Matthews, DA Lee, CA Ford, CE Burke, BJ Rejto, PA Hendrickson, TF Tuntland, T Brown, EL Meador, JW Ferre, RA Harr, JEV Kosa, MB Worland, ST
Citation: Ps. Dragovich et al., Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P-1 lactam moieties as L-glutamine replacements, J MED CHEM, 42(7), 1999, pp. 1213-1224
Risultati: 1-17 |